Prostate News Archive
09-Dec-2006
Hair-growth Drug Artificially Lowers PSA Levels In Prostate Cancer Screening, Study Finds (Science Daily)
The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen test, the standard screening test for prostate cancer, a multicenter study has found. Prostate cancer group schedules next meeting (Standard-Journal)
DANVILLE ? Dr. Sophia Drinis of the department of urology at Geisinger Health System will be the featured speaker at the Man to Man prostate Cancer Support Group Meeting at 7 p.m. Monday, Dec. 11, in the Pine Barn Inn. Spurs players help NBA fight prostate cancer (BizJournals)
The Prostate Cancer Foundation is partnering with the NBA and will sell wristbands representing 18 current and former players as part of an effort to raise funds to help find a cure for the disease. Cougar Biotechnology Presents Positive CB7630 Phase I data at the AACR Innovations in Prostate Cancer Research (Business Wire via Yahoo! Finance)
LOS ANGELES----Cougar Biotechnology, Inc., a publicly held biotechnology company, today announced positive Phase I data on the Company's prostate cancer drug candidate CB7630 . The data was presented last night during the poster session at the American Association for Cancer Research Innovations in prostate Cancer Research Conference that is currently taking place December 6-9, 2006 in San
Back to Prostate News Archive
